Health Insurance Legislation Amendment (2022 Measures No. 1) Regulations 2022 (Cth)

Case
No judgment structure available for this case.

Health Insurance Legislation Amendment (2022 Measures No. 1) Regulations 2022

I, General the Honourable David Hurley AC DSC (Retd), Governor‑General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulations.

Dated 17 March 2022

David Hurley

Governor‑General

By His Excellency’s Command

Greg Hunt

Minister for Health and Aged Care

Contents

1............ Name............................................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Authority....................................................................................................................... 1

4............ Schedules...................................................................................................................... 1

Schedule 1—Amendments  2

Part 1—Prostate‑specific membrane antigen positron emission tomography          2

Health Insurance (Diagnostic Imaging Services Table) Regulations (No. 2) 2020             2

Part 2—Bulk billing incentive—magnetic resonance imaging  3

Health Insurance (Diagnostic Imaging Services Table) Regulations (No. 2) 2020             3

Part 3—Genetic testing  4

Health Insurance (Pathology Services Table) Regulations 2020  4

Part 4—Cervical screening tests  11

Health Insurance (Pathology Services Table) Regulations 2020  11

Part 5—Colorectal surgery services  12

Health Insurance (General Medical Services Table) Regulations 2021  12

Part 6—Miscellaneous amendments  17

Health Insurance (Diagnostic Imaging Services Table) Regulations (No. 2) 2020           17

Health Insurance (General Medical Services Table) Regulations 2021  17

Part 7—Indexation  18

Health Insurance (Diagnostic Imaging Services Table) Regulations (No. 2) 2020           18

Health Insurance (General Medical Services Table) Regulations 2021  18

Health Insurance (Pathology Services Table) Regulations 2020  39

1  Name

This instrument is the Health Insurance Legislation Amendment (2022 Measures No. 1) Regulations 2022.

2  Commencement

(1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1 Column 2 Column 3
Provisions Commencement Date/Details
1.  Sections 1 to 4 and anything in this instrument not elsewhere covered by this table The day after this instrument is registered. 22 March 2022
2.  Schedule 1, Parts 1 to 6 1 July 2022. 1 July 2022
3.  Schedule 1, Part 7 Immediately after the commencement of the provisions covered by table item 2. 1 July 2022

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under the Health Insurance Act 1973.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

Part 1—Prostate‑specific membrane antigen positron emission tomography

Health Insurance (Diagnostic Imaging Services Table) Regulations (No. 2) 2020

1  Schedule 1 (after item 61560)

Insert:

61563

Whole body prostate‑specific membrane antigen PET study performed for the initial staging of intermediate to high‑risk prostate adenocarcinoma, for a previously untreated patient who is considered suitable for locoregional therapy with curative intent

Applicable once per lifetime (R)

 1,300.00
61564

Whole body prostate‑specific membrane antigen PET study performed for the restaging of recurrent prostate adenocarcinoma, for a patient who:

(a) has undergone prior locoregional therapy; and

(b) is considered suitable for further locoregional therapy to determine appropriate therapeutic pathways and timing of treatment initiation

Applicable twice per lifetime (R)

 1,300.00

Part 2—Bulk billing incentive—magnetic resonance imaging

Health Insurance (Diagnostic Imaging Services Table) Regulations (No. 2) 2020

2  Paragraph 1.2.18(1)(a) of Schedule 1

Omit “2.4”, substitute “2.5”.

3  Clause 1.2.19 of Schedule 1

Repeal the clause.

Part 3—Genetic testing

Health Insurance (Pathology Services Table) Regulations 2020

4  Schedule 1 (item 73325)

Repeal the item, substitute:

73325 Determination of JAK2 V617F variant allele frequency in the diagnostic work‑up by, or on behalf of, a specialist or consultant physician, for a patient with clinical and laboratory evidence of a myeloproliferative neoplasm 90.00

5  Schedule 1 (cell at item 73385, column 2)

Repeal the cell, substitute:

Genetic analysis, for a patient who is eligible for this service under clause 2.7.3A, of embryonic tissue from a sample from one embryo, if:

(a) the analysis is:

(i) requested by a specialist or consultant physician; and

(ii) for the purpose of providing a pre‑implantation genetic test; and

(iii) performed on an embryo that was produced in a single assisted reproductive treatment cycle; and

(b) the service is not a service to which item 73386 or 73387 applies for the same assisted reproductive treatment cycle

Applicable not more than once per embryo

6  Schedule 1 (cell at item 73386, column 2)

Repeal the cell, substitute:

Genetic analysis, for a patient who is eligible for this service under clause 2.7.3A, of embryonic tissue from samples from 2 embryos, if:

(a) the analysis is:

(i) requested by a specialist or consultant physician; and

(ii) for the purpose of providing a pre‑implantation genetic test; and

(iii) performed on embryos that were produced in a single assisted reproductive treatment cycle; and

(b) the service is not a service to which item 73385 or 73387 applies for the same assisted reproductive treatment cycle

Applicable not more than once per assisted reproductive treatment cycle for the 2 embryos tested

7  Schedule 1 (cell at item 73387, column 2)

Repeal the cell, substitute:

Genetic analysis, for a patient who is eligible for this service under clause 2.7.3A, of embryonic tissue from samples from 3 or more embryos, if:

(a) the analysis is:

(i) requested by a specialist or consultant physician; and

(ii) for the purpose of providing a pre‑implantation genetic test; and

(iii) performed on embryos that were produced in a single assisted reproductive treatment cycle; and

(b) the service is not a service to which item 73385 or 73386 applies for the same assisted reproductive treatment cycle

Applicable not more than once per assisted reproductive treatment cycle for the 3 or more embryos tested

8  Clause 2.7.4 of Schedule 1 (at the end of the table)

Add:

73392

Characterisation of pathogenic or likely pathogenic germline gene variants, requested by a specialist or consultant physician:

(a) in at least the following genes:

(i) MYBPC3;

(ii) MYH7;

(iii) TNNI3;

(iv) TNNT2;

(v) TPM1;

(vi) ACTC1;

(vii) MYL2;

(viii) MYL3;

(ix) PRKAG2;

(x) LAMP2;

(xi) GLA;

(xii) LMNA;

(xiii) SCN5A;

(xiv) TTN;

(xv) RBM20;

(xvi) PLN;

(xvii) DSP;

(xviii) DSC2;

(xix) DSG2;

(xx) JUP;

(xxi) PKP2;

(xxii) TMEM43; and

(b) for a patient for whom clinical history, family history or laboratory findings suggest there is a high probability of one or more of the following heritable cardiomyopathies in the patient:

(i) hypertrophic cardiomyopathy;

(ii) dilated cardiomyopathy;

(iii) arrhythmogenic cardiomyopathy

Applicable once per lifetime

 1,200.00
73393

Characterisation of one or more pathogenic or likely pathogenic germline gene variants, requested by a specialist or consultant physician, if:

(a) a service described in item 73392 has not previously been performed for the patient; and

(b) the patient is a first‑degree biological relative (or a second‑degree biological relative if a first‑degree biological relative is unavailable) of a person who has a pathogenic or likely pathogenic germline gene variant that is confirmed by laboratory findings; and

(c) the service is performed for the purpose of assessing present or future risk of any of the following heritable cardiomyopathies in the patient:

(i) hypertrophic cardiomyopathy;

(ii) dilated cardiomyopathy;

(iii) arrhythmogenic cardiomyopathy

Applicable once per variant per lifetime

 400.00
73394

Characterisation of one or more recessive pathogenic or likely pathogenic germline genes, requested by a specialist or consultant physician, for the purpose of determining the reproductive risk of heritable cardiomyopathy in a patient:

(a) who is a reproductive partner of a known carrier of a pathogenic or likely pathogenic germline gene that is confirmed by laboratory findings; and

(b) for whom carrier status of a pathogenic or likely pathogenic germline gene is unknown; and

(c) who has a clinical history, family history or laboratory findings suggesting there is a low probability of heritable cardiomyopathy

Applicable once per gene per lifetime

 1,200.00
73395

Re‑analysis of whole exome or genome data that is obtained in performing a service to which item 73392 applies, for characterisation of previously unreported germline gene variants related to the clinical phenotype, if:

(a) the re‑analysis is requested by a consultant physician practising as a clinical geneticist or a cardiologist; and

(b) the patient is strongly suspected of having a heritable cardiomyopathy; and

(c) the re‑analysis is performed at least 18 months after a service to which item 73392 or this item applies is performed for the patient

Applicable twice per lifetime

 500.00
73396 Characterisation of variants in the JAK2 exon 12 in the diagnostic work‑up of a patient with clinical and laboratory evidence of polycythaemia vera, requested by a specialist or consultant physician 90.00
73397 Characterisation of variants in both the CALR and MPL genes in the diagnostic work‑up of a patient with clinical and laboratory evidence of essential thrombocythaemia or primary myelofibrosis, requested by a specialist or consultant physician 200.00
73398

Characterisation of variants in at least 8 genes, which must include all of the following genes:

(a) JAK2 (including exons 12 and 14);

(b) CALR;

(c) MPL;

in the diagnostic work‑up of a patient with clinical and laboratory evidence of polycythaemia vera or essential thrombocythaemia, requested by a specialist or consultant physician

Applicable to one test per diagnostic episode

 420.00
73399

Characterisation of variants in at least 20 genes, which must include all of the following genes:

(a) JAK2 (including exons 12 and 14);

(b) CALR;

(c) MPL;

in the diagnostic work‑up of a patient, with clinical and laboratory evidence of primary myelofibrosis, who is eligible for a stem cell transplant, requested by a specialist or consultant physician

Applicable to one test per diagnostic episode

 700.00
73401

Characterisation, by whole exome or genome sequencing and analysis, of germline gene variants in one or more of the genes implicated in heritable cystic kidney disease, if:

(a) the service is requested by a consultant physician practising as:

(i) a clinical geneticist; or

(ii) a specialist nephrologist; and

(b) the patient has a renal abnormality and is strongly suspected of having a monogenic condition

Applicable once per lifetime

 2,100.00
73402

Characterisation, by whole exome or genome sequencing and analysis, of germline gene variants in one or more of the genes implicated in heritable kidney disease, if:

(a) the service is requested by a consultant physician practising as:

(i) a clinical geneticist; or

(ii) a specialist nephrologist; and

(b) the patient has chronic kidney disease (other than cystic disease or Alport syndrome) and is strongly suspected of having a monogenic condition

Applicable once per lifetime

 2,100.00
73403

Re‑analysis of genetic data obtained in performing a service to which item 73401 or 73402 applies, for characterisation of previously unreported germline gene variants related to the clinical phenotype, if:

(a) the re‑analysis is requested by a consultant physician practising as a clinical geneticist or a specialist paediatrician; and

(b) the patient has a strong clinical suspicion of a monogenic condition; and

(c) a service to which item 73401, 73402 or this item applies has not been performed for the patient in the previous 18 months

Applicable twice per lifetime

 500.00
73404

Detection of a single gene variant in a patient, if:

(a) the service is requested by:

(i) a clinical geneticist; or

(ii) a specialist or consultant physician providing professional genetic counselling services; and

(b) the patient has a first‑degree relative with a known monogenic cause of kidney disease; and

(c) a service described in item 73401, 73402, or 73403 has identified the causative variant for the disease for the relative

Applicable once per variant per lifetime

 400.00
73405

Detection of one or more variants of a single gene known to cause heritable kidney disease, for the purpose of reproductive decision making, if:

(a) the detection is requested by a consultant physician practising as:

(i) a clinical geneticist; or

(ii) a specialist nephrologist; and

(b) the patient is the reproductive partner of an individual known to be a carrier of a pathogenic variant that causes heritable kidney disease that has a recessive mode of inheritance; and

(c) a service described in item 73401, 73402, 73403 or 73404 has identified the causative gene for the patient’s partner; and

(d) the detection test methodology has sufficient diagnostic range and sensitivity to detect at least 95% of pathogenic variants likely to be present in the patient

 1,200.00
73406

Testing of a pregnant patient, for the purpose of determining whether monogenic variants are present in the fetus, if:

(a) the service is requested by a consultant physician practising as:

(i) a clinical geneticist; or

(ii) a specialist nephrologist; and

(b) the patient or the patient’s reproductive partner (or both) are known to be affected by, or are carriers of, a known pathogenic variant that causes heritable kidney disease; and

(c) the fetus is at risk, of at least 25%, of inheriting a monogenic variant known to cause kidney disease

 400.00
73410

Deletion testing of HBA1 and HBA2 for:

(a) the diagnosis of alpha thalassaemia in a patient of reproductive age:

(i) who has abnormal red cell indices; and

(ii) for whom thalassaemia screening for beta‑thalassaemia was not conclusive; and

(iii) who does not have a concurrent iron deficiency (or who, irrespective of iron status, is pregnant); and

(iv) who has no historic normal cell indices; or

(b) the determination of carrier status in a person:

(i) who is a reproductive partner of a person of child‑bearing potential with diagnosed alpha thalassaemia; and

(ii) who has abnormal red cell indices; and

(iii) who does not have a concurrent iron deficiency

 100.00
73411

Sequencing of HBA1 or HBA2, if the results of deletion testing described in item 73410 were inconclusive and a less common or rare variant is suspected, either:

(a) for the diagnosis of alpha thalassaemia in a patient of reproductive age; or

(b) for the determination of carrier status in a reproductive partner of a person of child‑bearing potential with diagnosed alpha thalassaemia

Applicable once per gene per lifetime

 400.00
73412

Deletion testing of HBA1 and HBA2, if the results of deletion testing described in item 73410 were inconclusive and a large deletion variant is suspected, either:

(a) for the diagnosis of alpha thalassaemia in a patient of reproductive age; or

(b) for the determination of carrier status in a reproductive partner of a person of child‑bearing potential with diagnosed alpha thalassaemia

 250.00
73413

Non‑deletion testing of HBA1 and HBA2 using techniques other than sequencing, if the results of deletion testing described in item 73410 were inconclusive, either:

(a) for the diagnosis of alpha thalassaemia in a patient of reproductive age; or

(b) for the determination of carrier status in a reproductive partner of a person of child‑bearing potential with diagnosed alpha thalassaemia

 250.00
73416

Detection of germline gene variants, including copy number variation, requested by a specialist or consultant physician:

(a) in at least the following genes:

(i) KCNQ1;

(ii) KCNH2;

(iii) SCN5A;

(iv) KCNE1;

(v) KCNE2;

(vi) KCNJ2;

(vii) CACNA1C;

(viii) RYR2;

(ix) CASQ2;

(x) CAV3;

(xi) SCN4B;

(xii) AKAP9;

(xiii) SNTA1;

(xiv) KCNJ5;

(xv) ALG10;

(xvi) CALM1;

(xvii) CALM2;

(xviii) ANK2;

(xix) TECRL;

(xx) TRDN; and

(b) for a patient for whom clinical or family history criteria is suggestive of inherited cardiac arrhythmias or channelopathies that place the patient at greater than 10% risk of having a pathogenic variant

Applicable once per lifetime

 1,200.00
73417

Characterisation of one or more pathogenic or likely pathogenic germline gene variants, requested by a specialist or consultant physician, if:

(a) the patient is a first‑degree or second‑degree biological relative of a person with a pathogenic or likely pathogenic germline gene variant that is confirmed by laboratory findings; and

(b) the service is performed for the purpose of assessing present or future risk of a cardiac arrhythmia or channelopathy; and

(c) a service to which item 73416 applies has not previously been performed for the patient

Applicable once per variant per lifetime

 400.00
73418

Characterisation of one or more recessive pathogenic or likely pathogenic germline genes, requested by a specialist or consultant physician, for the purpose of determining the reproductive risk of cardiac arrhythmia or channelopathy in a patient:

(a) who is a reproductive partner of a person who is a known carrier of a pathogenic or likely pathogenic germline gene variant of a gene confirmed by laboratory findings; and

(b) for whom a service to which item 73416 applies has not previously been performed; and

(c) for whom carrier status of a pathogenic or likely pathogenic germline gene variant is unknown; and

(d) who has a clinical history, family history or laboratory findings suggesting there is a low probability of cardiac arrhythmia or channelopathy

Applicable once per variant per lifetime

 400.00
73419

Re‑analysis of whole exome or genome data that was obtained in performing a service to which item 73416 applies, for characterisation of previously unreported germline gene variants related to the clinical phenotype, if:

(a) the re‑analysis is requested by a consultant physician practising as a clinical geneticist or a cardiologist; and

(b) the patient is strongly suspected of having inheritable cardiac arrhythmia or channelopathies; and

(c) the service is performed at least 18 months after a service to which item 73416 or this item applies was performed for the patient

Applicable twice per lifetime

 500.00
73420 Non‑invasive prenatal testing of blood from an RhD negative pregnant patient for the detection of the RHD gene from fetal DNA circulating in maternal blood 56.00
73421 Non‑invasive prenatal testing of blood from an RhD negative pregnant patient (in a singleton pregnancy) for the detection of the RHD gene from fetal DNA circulating in maternal blood, if the patient is alloimmunised with immune Anti‑D 550.00

Part 4—Cervical screening tests

Health Insurance (Pathology Services Table) Regulations 2020

9  Schedule 1 (cell at item 73071, column 2)

Repeal the cell, substitute:

A test, including partial genotyping, for oncogenic human papillomavirus that may be associated with cervical pre‑cancer or cancer, if performed:

(a) on a self‑collected vaginal specimen; and

(b) for an asymptomatic patient who is at least 24 years and 9 months of age

For any particular patient, applicable once in 57 months

10  Schedule 1 (item 73073, column 2)

Omit “For any particular patient, once only in 21 months”.

Part 5—Colorectal surgery services

Health Insurance (General Medical Services Table) Regulations 2021

11  Clause 5.10.14 of Schedule 1 (heading)

Omit “items 32220 and”, substitute “item”.

12  Clause 5.10.14 of Schedule 1

Omit “items 32220 and”, substitute “item”.

13  Schedule 1 (items 32004 and 32005, column 2)

Omit “or 32006”, substitute “, 32006 or 32030”.

14  Schedule 1 (cell at item 32006, column 2)

Repeal the cell, substitute:

Left hemicolectomy, including the descending and sigmoid colon (including formation of stoma), if associated with a service to which item 32024, 32025, 32026 or 32028 applies (H) (Anaes.) (Assist.)

15  Schedule 1 (items 32024 and 32025, column 2)

Omit “32103, 32104 or 32106”, substitute “32000, 32030, 32106 or 32232”.

16  Schedule 1 (item 32026)

Repeal the item, substitute:

32026 Rectum, ultra‑low restorative resection, with or without covering stoma and with or without colonic reservoir, if the anastomosis is sited in the anorectal region and is 6 cm or less from the anal verge, not being a service associated with a service to which item 32000, 32030, 32106, 32117 or 32232 applies (H) (Anaes.) (Assist.) 2,160.65

17  Schedule 1 (item 32028)

Repeal the item, substitute:

32028 Rectum, low or ultra-low restorative resection, with per anal sutured coloanal anastomosis, with or without covering stoma and with or without colonic reservoir, not being a service associated with a service to which item 32000, 32030, 32106, 32117 or 32232 applies (H) (Anaes.) (Assist.) 2,295.15

18  Schedule 1 (item 32030, column 2)

Omit “—(Hartmann’s operation)”, substitute “, including formation of stoma”.

19  Schedule 1 (item 32033, column 2)

Omit “following Hartmann’s”, substitute “continuity following rectosigmoidectomy”.

20  Schedule 1 (cell at item 32060, column 2)

Repeal the cell, substitute:

Restorative proctectomy, involving rectal resection with formation of ileal reservoir and ileoanal anastomosis, including ileostomy mobilisation, with or without mucosectomy or temporary loop ileostomy, 1 surgeon (H) (Anaes.) (Assist.)

21  Schedule 1 (item 32096, column 2)

After “full thickness,”, insert “to diagnose or exclude Hirschsprung’s Disease,”.

22  Schedule 1 (cell at item 32106, column 2)

Repeal the cell, substitute:

Anterolateral intraperitoneal rectal tumour, per anal excision of, using rectoscopy digital viewing system and pneumorectum, if:

(a) clinically appropriate; and

(b) removal requires dissection within the peritoneal cavity;

excluding use of a colonoscope as the operating platform and not being a service associated with a service to which item 32024, 32025 or 32232 applies (Anaes.) (Assist.)

23  Schedule 1 (item 32117)

Repeal the item, substitute:

32117 Rectal prolapse, abdominal rectopexy of, excluding ventral mesh rectopexy, not being a service associated with a service to which item 32025 or 32026 applies (H) (Anaes.) (Assist.) 1,328.00

24  Schedule 1 (item 32129, column 2)

Omit “, direct repair of”, substitute “repair”.

25  Schedule 1 (cell at item 32135, column 2)

Repeal the cell, substitute:

Treatment of haemorrhoids or rectal prolapse, including rubber band ligation or sclerotherapy for, not being a service to which item 32139 applies (Anaes.)

26  Schedule 1 (cell at item 32139, column 2)

Repeal the cell, substitute:

Operative treatment of haemorrhoids involving third‑degree or fourth‑degree haemorrhoids, including excision of anal skin tags when performed, not being a service associated with a service to which item 32135 or 32233 applies (H) (Anaes.) (Assist.)

27  Schedule 1 (cell at item 32150, column 2)

Repeal the cell, substitute:

Operation for anal fissure, including excision, injection of Botulinum toxin or sphincterotomy, excluding dilatation (Anaes.) (Assist.)

28  Schedule 1 (item 32156, column 2)

Omit “Fistula‑in‑ano”, substitute “Anal fistula”.

29  Schedule 1 (cell at item 32165, column 2)

Repeal the cell, substitute:

Operative treatment of anal fistula, repair by mucosal advancement flap, including ligation of inter‑sphincteric fistula tract (LIFT) or other complex sphincter sparing surgery (Anaes.) (Assist.)

30  Schedule 1 (item 32171, column 2)

After “anaesthetic,”, insert “with or without faecal disimpaction,”.

31  Schedule 1 (cell at item 32213, column 2)

Repeal the cell, substitute:

Sacral nerve lead or leads, placement of, percutaneous or open, including intraoperative test stimulation and programming, for the management of faecal incontinence (H) (Anaes.)

32  Schedule 1 (cell at item 32215, column 2)

Repeal the cell, substitute:

Sacral nerve electrode or electrodes, management, adjustment and electronic programming of the neurostimulator by a medical practitioner, to manage faecal incontinence, not being a service associated with a service to which item 32213, 32216, 32218 or 32237 applies

Applicable once per day for the same patient by the same practitioner

33  Schedule 1 (cell at item 32216, column 2)

Repeal the cell, substitute:

Sacral nerve lead or leads, inserted for the management of faecal incontinence in a patient with faecal incontinence refractory to conservative non‑surgical treatment, either:

(a) percutaneous surgical repositioning of the lead or leads, using fluoroscopic guidance; or

(b) open surgical repositioning of the lead or leads;

to correct displacement or unsatisfactory positioning (including intraoperative test stimulation), not being a service associated with a service to which item 32213 applies (H) (Anaes.)

34  Schedule 1 (cell at item 32218, column 2)

Repeal the cell, substitute:

Sacral nerve lead or leads, removal (H) (Anaes.)

35  Schedule 1 (at the end of Subgroup 2 of Group T8)

Add:

32231 Rectal tumour, per anal excision of (H) (Anaes.) (Assist.) 352.30
32232 Rectal tumour, per anal excision of, using a rectoscopy digital viewing system and pneumorectum if clinically appropriate and excluding use of a colonoscope as the operating platform, not being a service associated with a service to which item 32024, 32025 or 32106 applies (H) (Anaes.) (Assist.) 955.15
32233 Perineal repair of rectal prolapse, not being a service associated with a service to which item 32139 applies (H) (Anaes.) (Assist.) 678.40
32234 Rectal stricture, treatment of (H) (Anaes.) 134.15
32235 Anal skin tags or anal polyps, excision of one or more of (Anaes.) 129.50
32236 Anal warts, removal of, under general anaesthesia, or under regional or field nerve block (excluding pudendal block), not being a service associated with a service to which item 35507 or 35508 applies (H) (Anaes.) 184.20
32237 Neurostimulator or receiver, subcutaneous placement of, replacement of, or removal of, including programming and placement and connection of an extension wire or wires to sacral nerve electrode(s), for the management of faecal incontinence (H) (Anaes.) (Assist.) 298.75

36  Schedule 1 (items 35507 and 35508, column 2)

Omit “32177 or 32180”, substitute “32236”.

37  Amendments of listed provisions—repeals

Repeal the following table items in Schedule 1:

(a)  item 32029;

(b)  item 32099;

(c)  item 32102;

(d)  item 32103;

(e)  item 32104;

(f)  item 32111;

(g)  item 32112;

(h)  item 32114;

(i)  item 32115;

(j)  item 32120;

(k)  item 32126;

(l)  item 32132;

(m)  item 32138;

(n)  item 32142;

(o)  item 32145;

(p)  item 32153;

(q)  item 32168;

(r)  item 32177;

(s)  item 32180;

(t)  item 32200;

(u)  item 32203;

(v)  item 32206;

(w)  item 32209;

(x)  item 32210;

(y)  item 32214;

(z)  item 32217;

(za)  item 32220.

Part 6—Miscellaneous amendments

Health Insurance (Diagnostic Imaging Services Table) Regulations (No. 2) 2020

38  Paragraph 2.5.9A(1)(b) of Schedule 1

Omit “subsection”, substitute “subclause”.

39  Subclauses 2.5.9A(2), (3), (4), (5) and (6) of Schedule 1

Omit “subsection”, substitute “subclause”.

Health Insurance (General Medical Services Table) Regulations 2021

40  Subclause 1.1.6(1) of Schedule 1

Omit “131,”.

41  Schedule 1 (item 11607, column 2, paragraph (g))

Repeal the paragraph, substitute:

(g) the service:

(i) is not provided in association with ambulatory electrocardiogram recording; and

(ii) is not associated with a service to which any of the following items apply:

(A) 177;

(B) 224 to 228;

(C) 229 to 244;

(D) 699;

(E) 701 to 707;

(F) 715

(G) 721 to 732;

(H) 735 to 758.

42  Schedule 1 (item 35750, column 2)

Omit “applies. (Anaes.)”, substitute “applies (H) (Anaes.)”.

43  Paragraph 5.2.4(1)(b) of Schedule 1

After “Group T1”, insert “or item 73384, 73385, 73386 or 73387 of the pathology services table”.

Part 7—Indexation

Health Insurance (Diagnostic Imaging Services Table) Regulations (No. 2) 2020

44  Clause 2.1.18 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group I1 are indexed in accordance with clause 2.7.1.

45  Clauses 2.5.10, 2.5.13, 2.5.14, 2.5.15 and 2.5.16 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group I5 are indexed in accordance with clause 2.7.1.

46  Subclause 2.7.1(1) of Schedule 1 (heading)

Omit “1 July 2021”, substitute “1 July 2022”.

47  Subclause 2.7.1(1) of Schedule 1 (including the note)

Repeal the subclause, substitute:

(1)  On 1 July 2022 (the indexation day), each amount covered by subclause (2) is replaced by the amount worked out using the following formula:

Note:          The indexed fees could in 2022 be viewed on the Department of Health’s MBS Online website ( Subparagraph 2.7.1(2)(a)(iv) of Schedule 1

Repeal the subparagraph, substitute:

(iv)  Group I5 (magnetic resonance imaging services);

(v)  Group I6 (bulk‑billed services);

Health Insurance (General Medical Services Table) Regulations 2021

49  Paragraph 1.2.4(2)(c) of Schedule 1

Omit “$312.15”, substitute “$317.15”.

50  At the end of Part 1 of Schedule 1

Add:

Division 1.3—Indexation of fees

1.3.1  Indexation—1 July 2022

(1)  On 1 July 2022 (the indexation day), each amount covered by subclause (2) is replaced by the amount worked out using the following formula:

Note:          The indexed fees could in 2022 be viewed on the Department of Health’s MBS Online website ( (2)  The amounts covered by this subclause are the fee for each item in a Group in this Schedule, other than the fee for the following:

(a)  an item in Group A2;

(b)  item 173 in Group A7;

(c)  an item in Group A19;

(d)  an item in Group A23;

(e)  items 90092, 90093, 90095 and 90096 in Group A35;

(f)  items 90254, 90255, 90256, 90257, 90265, 90275, 90277, 90281 and 90282 in Group A36;

(g)  items 32026, 32028, 32117, 32231, 32232, 32233, 32234, 32235, 32236 and 32237 in Group T8;

(h)  an item in Group T10.

(3)  To avoid doubt, a fee listed in any of the following items is not indexed under subclause (1):

(a)  items in a Group that list the fee as a percentage of a fee listed in another item in the Group;

(b)  items in a Group that list the fee as an amount under a specified clause in this Schedule;

(c)  a table item of the following tables:

(i)  table 2.1.1;

(ii)  table 2.20.2;

(iii)  table 5.3.1.

(4)  An amount worked out under subclause (1) is to be rounded up or down to the nearest 5 cents (rounding down if the amount is an exact multiple of 2.5 cents).

51  Clause 2.2.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A1 are indexed in accordance with clause 1.3.1.

52  Clause 2.4.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A3 are indexed in accordance with clause 1.3.1.

53  Schedule 1 (item 111, column 2, paragraph (d))

Omit “$312.15”, substitute “$317.15”.

54  Schedule 1 (item 115, column 2, paragraph (c))

Omit “$312.15”, substitute “$317.15”.55  Clause 2.5.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A4 are indexed in accordance with clause 1.3.1.

56  Schedule 1 (item 117, column 2, paragraph (e))

Omit “$312.15”, substitute “$317.15”.

57  Schedule 1 (item 120, column 2, paragraph (d))

Omit “$312.15”, substitute “$317.15”.58  Clause 2.6.3 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A29 are indexed in accordance with clause 1.3.1.

59  Clause 2.7.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A28 are indexed in accordance with clause 1.3.1.

60  Clause 2.8.2 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A5 are indexed in accordance with clause 1.3.1.

61  Clause 2.9.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A6 are indexed in accordance with clause 1.3.1.

62  Clause 2.10.2 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A7 are indexed in accordance with clause 1.3.1.

63  Clause 2.11.5 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A8 are indexed in accordance with clause 1.3.1.

64  Clause 2.12.2 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A12 are indexed in accordance with clause 1.3.1.

65  Clause 2.13.2 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A13 are indexed in accordance with clause 1.3.1.

66  Clause 2.14.5 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A11 are indexed in accordance with clause 1.3.1.

67  Clause 2.15.15 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A14 are indexed in accordance with clause 1.3.1.

68  Clause 2.16.13 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A15 are indexed in accordance with clause 1.3.1.

69  Clause 2.16.20 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A15 are indexed in accordance with clause 1.3.1.

70  Clause 2.17.4 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A17 are indexed in accordance with clause 1.3.1.

71  Clause 2.19.3 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A18 are indexed in accordance with clause 1.3.1.

72  Clause 2.20.8 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A20 are indexed in accordance with clause 1.3.1.

73  Clause 2.21.4 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A24 are indexed in accordance with clause 1.3.1.

74  Clause 2.22.2 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A27 are indexed in accordance with clause 1.3.1.

75  Clause 2.23.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A21 are indexed in accordance with clause 1.3.1.

76  Clause 2.24.2 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A22 are indexed in accordance with clause 1.3.1.

77  Clause 2.26.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A26 are indexed in accordance with clause 1.3.1.

78  Clause 2.27.4 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A31 are indexed in accordance with clause 1.3.1.

79  Clause 2.28.3 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A32 are indexed in accordance with clause 1.3.1.

80  Clause 2.29.2 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A9 are indexed in accordance with clause 1.3.1.

81  Clause 2.30.2 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A35 are indexed in accordance with clause 1.3.1.

82  Clause 2.31.10 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A36 are indexed in accordance with clause 1.3.1.

83  Clause 2.32.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group A37 are indexed in accordance with clause 1.3.1.

84  Clause 3.1.4 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group M12 are indexed in accordance with clause 1.3.1.

85  Clause 3.2.3 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group M1 are indexed in accordance with clause 1.3.1.

86  Clause 4.1.5 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group D1 are indexed in accordance with clause 1.3.1.

87  Clause 4.2.2 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group D2 are indexed in accordance with clause 1.3.1.

88  Clause 5.2.10 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T1 are indexed in accordance with clause 1.3.1.

89  Clause 5.3.4 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T2 are indexed in accordance with clause 1.3.1.

90  Clause 5.4.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T3 are indexed in accordance with clause 1.3.1.

91  Clause 5.5.4 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T4 are indexed in accordance with clause 1.3.1.

92  Clause 5.6.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T6 are indexed in accordance with clause 1.3.1.

93  Subclause 5.7.1(1) of Schedule 1 (paragraph (b) of the definition of amount under clause 5.7.1)

Omit “$19.80”, substitute “$20.10”.

94  Subclause 5.7.1(2) of Schedule 1 (paragraph (b) of the definition of amount under clause 5.7.1)

Omit “$29.75”, substitute “$30.25”.

95  Clause 5.7.2 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T7 are indexed in accordance with clause 1.3.1.

96  Clause 5.8.3 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T11 are indexed in accordance with clause 1.3.1.

97  Clause 5.10.9 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T8 are indexed in accordance with clause 1.3.1.

98  Clause 5.10.16 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T8 are indexed in accordance with clause 1.3.1.

99  Clause 5.10.18 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T8 are indexed in accordance with clause 1.3.1.

100  Clause 5.10.19 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T8 are indexed in accordance with clause 1.3.1.

101  Clause 5.10.23 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T8 are indexed in accordance with clause 1.3.1.

102  Clause 5.10.24 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T8 are indexed in accordance with clause 1.3.1.

103  Clause 5.10.29 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T8 are indexed in accordance with clause 1.3.1.

104  Clause 5.11.5 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group T9 are indexed in accordance with clause 1.3.1.

105  Schedule 1 (items 51300 and 51303, column 2)

Omit “$580.95”, substitute “$590.25”.106  Clause 6.2.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group O1 are indexed in accordance with clause 1.3.1.

107  Clause 6.3.3 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group O2 are indexed in accordance with clause 1.3.1.

108  Schedule 1 (items 51800 and 51803, column 2)

Omit “$580.95”, substitute “$590.25”.109  Clause 6.4.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group O3 are indexed in accordance with clause 1.3.1.

110  Clause 6.5.2 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group O4 are indexed in accordance with clause 1.3.1.

111  Clause 6.6.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group O5 are indexed in accordance with clause 1.3.1.

112  Clause 6.7.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group O6 are indexed in accordance with clause 1.3.1.

113  Clause 6.8.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group O7 are indexed in accordance with clause 1.3.1.

114  Clause 6.9.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group O8 are indexed in accordance with clause 1.3.1.

115  Clause 6.10.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group O9 are indexed in accordance with clause 1.3.1.

116  Clause 6.11.1 of Schedule 1 (before the table)

Insert:

Note:          The fees in Group O11 are indexed in accordance with clause 1.3.1.

117  Amendments of listed provisions—clause 2.1.1 of Schedule 1

The items of the table in clause 2.1.1 of Schedule 1 listed in the following table are amended as set out in the table.

Amendments relating to indexation—amounts if more, or not more, than 6 patients
Item Table item Omit Substitute
1 Table item 1 27.40 27.85
2 Table item 1 2.15 2.20
3 Table item 2 27.40 27.85
4 Table item 2 2.15 2.20
5 Table item 3 27.40 27.85
6 Table item 3 2.15 2.20
7 Table item 4 27.40 27.85
8 Table item 4 2.15 2.20
9 Table item 10 26.90 27.35
10 Table item 10 2.10 2.15
11 Table item 11 26.90 27.35
12 Table item 11 2.10 2.15
13 Table item 12 26.90 27.35
14 Table item 12 2.10 2.15
15 Table item 13 26.90 27.35
16 Table item 13 2.10 2.15
17 Table item 14 27.00 27.45
18 Table item 14 2.10 2.15
19 Table item 15 27.00 27.45
20 Table item 15 2.10 2.15
21 Table item 16 27.00 27.45
22 Table item 16 2.10 2.15
23 Table item 17 27.00 27.45
24 Table item 17 2.10 2.15
25 Table item 18 27.00 27.45
26 Table item 18 2.10 2.15
27 Table item 19 27.00 27.45
28 Table item 19 2.10 2.15
29 Table item 20 27.00 27.45
30 Table item 20 2.10 2.15
31 Table item 21 27.00 27.45
32 Table item 21 2.10 2.15
33 Table item 22 27.00 27.45
34 Table item 22 2.10 2.15
35 Table item 23 27.00 27.45
36 Table item 23 2.10 2.15
37 Table item 24 48.60 49.40
38 Table item 24 3.45 3.50
39 Table item 25 27.00 27.45
40 Table item 25 2.10 2.15
41 Table item 26 48.60 49.40
42 Table item 26 3.45 3.50
43 Table item 27 27.00 27.45
44 Table item 27 2.10 2.15
45 Table item 28 48.60 49.40
46 Table item 28 3.45 3.50
47 Table item 29 27.00 27.45
48 Table item 29 2.10 2.15
49 Table item 30 48.60 49.40
50 Table item 30 3.45 3.50
51 Table item 39 27.00 27.45
52 Table item 39 2.10 2.15
53 Table item 40 27.00 27.45
54 Table item 40 2.10 2.15
55 Table item 41 21.60 21.95
56 Table item 41 1.70 1.75
57 Table item 42 21.60 21.95
58 Table item 42 1.70 1.75

118  Amendments of listed provisions—clause 2.20.2 of Schedule 1

The items of the table in clause 2.20.2 of Schedule 1 listed in the following table are amended as set out in the table.

Amendments relating to indexation—amounts if more, or not more, than 6 patients
Item Table item Omit Substitute
1 Table item 1 27.00 27.45
2 Table item 1 2.10 2.15
3 Table item 2 27.00 27.45
4 Table item 2 2.10 2.15

119  Amendments of listed provisions—clause 5.3.1 of Schedule 1

The items of the table in clause 5.3.1 of Schedule 1 listed in the following table are amended as set out in the table.

Amendments relating to indexation
Item Table item Omit Substitute
1 Table item 1 17.75 18.05
2 Table item 2 19.30 19.60
3 Table item 3 19.55 19.85
4 Table item 4 23.60 24.00
5 Table item 5 49.20 50.00
6 Table item 6 33.20 33.75
7 Table item 7 39.50 40.15
8 Table item 8 39.50 40.15
9 Table item 9 39.50 40.15
10 Table item 10 39.50 40.15
11 Table item 11 39.50 40.15
12 Table item 12 39.50 40.15
13 Table item 13 39.50 40.15
14 Table item 14 39.50 40.15
15 Table item 15 39.50 40.15
16 Table item 16 39.50 40.15

120  Amendments of listed provisions—eating disorder services

The items of Schedule 1 listed in the following table are amended as set out in the table.

Amendments relating to indexation
Item Item of Schedule 1 Omit Substitute
1 Item 90254 59.70 60.65
2 Item 90255 87.90 89.30
3 Item 90256 75.80 77.00
4 Item 90257 111.65 113.45
5 Item 90265 59.70 60.65
6 Item 90275 77.20 78.45
7 Item 90277 110.50 112.25
8 Item 90281 77.20 78.45
9 Item 90282 110.50 112.25

121  Amendments of listed provisions—Group T10

The items of Schedule 1 listed in the following table are amended as set out in the table.

Amendments relating to indexation
Item Item of Schedule 1 Omit Substitute
1 Item 20100 103.00 104.75
2 Item 20102 123.60 125.70
3 Item 20104 82.40 83.80
4 Item 20120 103.00 104.75
5 Item 20124 82.40 83.80
6 Item 20140 103.00 104.75
7 Item 20142 103.00 104.75
8 Item 20143 123.60 125.70
9 Item 20144 144.20 146.65
10 Item 20145 144.20 146.65
11 Item 20146 103.00 104.75
12 Item 20147 123.60 125.70
13 Item 20148 82.40 83.80
14 Item 20160 123.60 125.70
15 Item 20162 144.20 146.65
16 Item 20164 82.40 83.80
17 Item 20170 123.60 125.70
18 Item 20172 144.20 146.65
19 Item 20174 185.40 188.55
20 Item 20176 206.00 209.50
21 Item 20190 103.00 104.75
22 Item 20192 206.00 209.50
23 Item 20210 309.00 314.25
24 Item 20212 103.00 104.75
25 Item 20214 185.40 188.55
26 Item 20216 412.00 419.00
27 Item 20220 206.00 209.50
28 Item 20222 123.60 125.70
29 Item 20225 247.20 251.40
30 Item 20300 103.00 251.40
31 Item 20305 309.00 314.25
32 Item 20320 123.60 125.70
33 Item 20321 206.00 209.50
34 Item 20330 164.80 167.60
35 Item 20350 206.00 209.50
36 Item 20352 103.00 104.75
37 Item 20355 247.20 251.40
38 Item 20400 61.80 62.85
39 Item 20401 82.40 83.80
40 Item 20402 103.00 104.75
41 Item 20403 103.00 104.75
42 Item 20404 123.60 125.70
43 Item 20405 164.80 167.60
44 Item 20406 267.80 272.35
45 Item 20410 82.40 83.80
46 Item 20420 103.00 104.75
47 Item 20440 82.40 83.80
48 Item 20450 103.00 104.75
49 Item 20452 123.60 125.70
50 Item 20470 123.60 125.70
51 Item 20472 206.00 209.50
52 Item 20474 267.80 272.35
53 Item 20475 206.00 209.50
54 Item 20500 309.00 314.25
55 Item 20520 123.60 125.70
56 Item 20522 82.40 83.80
57 Item 20524 82.40 83.80
58 Item 20526 206.00 209.50
59 Item 20528 164.80 167.60
60 Item 20540 267.80 272.35
61 Item 20542 309.00 314.25
62 Item 20546 309.00 314.25
63 Item 20548 309.00 314.25
64 Item 20560 412.00 419.00
65 Item 20600 206.00 209.50
66 Item 20604 267.80 272.35
67 Item 20620 206.00 209.50
68 Item 20622 267.80 272.35
69 Item 20630 164.80 167.60
70 Item 20632 144.20 146.65
71 Item 20634 206.00 209.50
72 Item 20670 267.80 272.35
73 Item 20680 61.80 62.85
74 Item 20690 103.00 104.75
75 Item 20700 61.80 62.85
76 Item 20702 82.40 83.80
77 Item 20703 82.40 83.80
78 Item 20704 206.00 209.50
79 Item 20706 144.20 146.65
80 Item 20730 103.00 104.75
81 Item 20740 103.00 104.75
82 Item 20745 144.20 146.65
83 Item 20750 103.00 104.75
84 Item 20752 123.60 125.70
85 Item 20754 144.20 146.65
86 Item 20756 185.40 188.55
87 Item 20770 309.00 314.25
88 Item 20790 164.80 167.60
89 Item 20791 206.00 209.50
90 Item 20792 267.80 272.35
91 Item 20793 309.00 314.25
92 Item 20794 247.20 251.40
93 Item 20798 206.00 209.50
94 Item 20799 123.60 125.70
95 Item 20800 61.80 62.85
96 Item 20802 103.00 104.75
97 Item 20803 82.40 83.80
98 Item 20804 206.00 209.50
99 Item 20806 144.20 146.65
100 Item 20810 82.40 83.80
101 Item 20815 123.60 125.70
102 Item 20820 103.00 104.75
103 Item 20830 82.40 83.80
104 Item 20832 123.60 125.70
105 Item 20840 123.60 125.70
106 Item 20841 164.80 167.60
107 Item 20842 82.40 83.80
108 Item 20844 206.00 209.50
109 Item 20845 206.00 209.50
110 Item 20846 206.00 209.50
111 Item 20847 206.00 209.50
112 Item 20848 206.00 209.50
113 Item 20850 247.20 251.40
114 Item 20855 309.00 314.25
115 Item 20860 123.60 125.70
116 Item 20862 144.20 146.65
117 Item 20863 206.00 209.50
118 Item 20864 206.00 209.50
119 Item 20866 206.00 209.50
120 Item 20867 206.00 209.50
121 Item 20868 206.00 209.50
122 Item 20880 309.00 314.25
123 Item 20882 206.00 209.50
124 Item 20884 103.00 104.75
125 Item 20886 123.60 125.70
126 Item 20900 61.80 62.85
127 Item 20902 82.40 83.80
128 Item 20904 144.20 146.65
129 Item 20905 206.00 209.50
130 Item 20906 82.40 83.80
131 Item 20910 82.40 83.80
132 Item 20911 103.00 104.75
133 Item 20912 103.00 104.75
134 Item 20914 144.20 146.65
135 Item 20916 144.20 146.65
136 Item 20920 82.40 83.80
137 Item 20924 82.40 83.80
138 Item 20926 82.40 83.80
139 Item 20928 123.60 125.70
140 Item 20930 82.40 83.80
141 Item 20932 82.40 83.80
142 Item 20934 123.60 125.70
143 Item 20936 164.80 167.60
144 Item 20938 82.40 83.80
145 Item 20940 82.40 83.80
146 Item 20942 103.00 104.75
147 Item 20943 82.40 83.80
148 Item 20944 123.60 125.70
149 Item 20946 164.80 167.60
150 Item 20948 82.40 83.80
151 Item 20950 103.00 104.75
152 Item 20952 82.40 83.80
153 Item 20954 206.00 209.50
154 Item 20956 82.40 83.80
155 Item 20958 103.00 104.75
156 Item 20960 144.20 146.65
157 Item 21100 61.80 62.85
158 Item 21110 103.00 104.75
159 Item 21112 82.40 83.80
160 Item 21114 103.00 104.75
161 Item 21116 123.60 125.70
162 Item 21120 123.60 125.70
163 Item 21130 61.80 62.85
164 Item 21140 309.00 314.25
165 Item 21150 206.00 209.50
166 Item 21155 206.00 209.50
167 Item 21160 82.40 83.80
168 Item 21170 164.80 167.60
169 Item 21195 61.80 62.85
170 Item 21199 82.40 83.80
171 Item 21200 82.40 83.80
172 Item 21202 82.40 83.80
173 Item 21210 123.60 125.70
174 Item 21212 206.00 209.50
175 Item 21214 206.00 209.50
176 Item 21216 288.40 293.30
177 Item 21220 82.40 83.80
178 Item 21230 123.60 125.70
179 Item 21232 103.00 104.75
180 Item 21234 164.80 167.60
181 Item 21260 82.40 83.80
182 Item 21270 164.80 167.60
183 Item 21272 82.40 83.80
184 Item 21274 123.60 125.70
185 Item 21275 206.00 209.50
186 Item 21280 309.00 314.25
187 Item 21300 61.80 62.85
188 Item 21321 82.40 83.80
189 Item 21340 82.40 83.80
190 Item 21360 103.00 104.75
191 Item 21380 61.80 62.85
192 Item 21382 82.40 83.80
193 Item 21390 61.80 62.85
194 Item 21392 82.40 83.80
195 Item 21400 82.40 83.80
196 Item 21402 144.20 146.65
197 Item 21403 206.00 209.50
198 Item 21404 103.00 104.75
199 Item 21420 61.80 62.85
200 Item 21430 82.40 83.80
201 Item 21432 103.00 104.75
202 Item 21440 164.80 167.60
203 Item 21445 206.00 209.50
204 Item 21460 61.80 62.85
205 Item 21461 82.40 83.80
206 Item 21462 61.80 62.85
207 Item 21464 82.40 83.80
208 Item 21472 103.00 104.75
209 Item 21474 103.00 104.75
210 Item 21480 82.40 83.80
211 Item 21482 103.00 104.75
212 Item 21484 103.00 104.75
213 Item 21486 144.20 146.65
214 Item 21490 61.80 62.85
215 Item 21500 164.80 167.60
216 Item 21502 123.60 125.70
217 Item 21520 82.40 83.80
218 Item 21522 103.00 104.75
219 Item 21530 309.00 314.25
220 Item 21532 164.80 167.60
221 Item 21535 206.00 209.50
222 Item 21600 61.80 62.85
223 Item 21610 103.00 104.75
224 Item 21620 82.40 83.80
225 Item 21622 103.00 104.75
226 Item 21630 103.00 104.75
227 Item 21632 123.60 125.70
228 Item 21634 185.40 188.55
229 Item 21636 309.00 314.25
230 Item 21638 206.00 209.50
231 Item 21650 164.80 167.60
232 Item 21652 206.00 209.50
233 Item 21654 164.80 167.60
234 Item 21656 206.00 209.50
235 Item 21670 82.40 83.80
236 Item 21680 61.80 62.85
237 Item 21682 82.40 83.80
238 Item 21685 206.00 209.50
239 Item 21700 61.80 62.85
240 Item 21710 82.40 83.80
241 Item 21712 103.00 104.75
242 Item 21714 103.00 104.75
243 Item 21716 103.00 104.75
244 Item 21730 61.80 62.85
245 Item 21732 82.40 83.80
246 Item 21740 103.00 104.75
247 Item 21756 123.60 125.70
248 Item 21760 144.20 146.65
249 Item 21770 164.80 167.60
250 Item 21772 123.60 125.70
251 Item 21780 82.40 83.80
252 Item 21785 206.00 209.50
253 Item 21790 309.00 314.25
254 Item 21800 61.80 62.85
255 Item 21810 82.40 83.80
256 Item 21820 61.80 62.85
257 Item 21830 82.40 83.80
258 Item 21832 144.20 146.65
259 Item 21834 82.40 83.80
260 Item 21840 164.80 167.60
261 Item 21842 123.60 125.70
262 Item 21850 82.40 83.80
263 Item 21860 61.80 62.85
264 Item 21865 206.00 209.50
265 Item 21870 309.00 314.25
266 Item 21872 164.80 167.60
267 Item 21878 61.80 62.85
268 Item 21879 103.00 104.75
269 Item 21880 144.20 146.65
270 Item 21881 185.40 188.55
271 Item 21882 226.60 230.45
272 Item 21883 267.80 272.35
273 Item 21884 309.00 314.25
274 Item 21885 350.20 356.15
275 Item 21886 391.40 398.05
276 Item 21887 432.60 439.95
277 Item 21900 61.80 62.85
278 Item 21906 103.00 104.75
279 Item 21908 123.60 125.70
280 Item 21910 185.40 188.55
281 Item 21912 103.00 104.75
282 Item 21914 123.60 125.70
283 Item 21915 103.00 104.75
284 Item 21916 103.00 104.75
285 Item 21918 103.00 104.75
286 Item 21922 123.60 125.70
287 Item 21925 82.40 83.80
288 Item 21926 82.40 83.80
289 Item 21930 123.60 125.70
290 Item 21935 103.00 104.75
291 Item 21936 103.00 104.75
292 Item 21939 61.80 62.85
293 Item 21941 144.20 146.65
294 Item 21942 206.00 209.50
295 Item 21943 103.00 104.75
296 Item 21945 103.00 104.75
297 Item 21949 103.00 104.75
298 Item 21952 82.40 83.80
299 Item 21955 103.00 104.75
300 Item 21959 103.00 104.75
301 Item 21962 103.00 104.75
302 Item 21965 103.00 104.75
303 Item 21969 164.80 167.60
304 Item 21970 309.00 314.25
305 Item 21973 103.00 104.75
306 Item 21976 103.00 104.75
307 Item 21980 103.00 104.75
308 Item 21990 61.80 62.85
309 Item 21992 82.40 83.80
310 Item 21997 82.40 83.80
311 Item 22002 82.40 83.80
312 Item 22007 82.40 83.80
313 Item 22008 82.40 83.80
314 Item 22012 61.80 62.85
315 Item 22014 61.80 62.85
316 Item 22015 123.60 125.70
317 Item 22020 82.40 83.80
318 Item 22025 82.40 83.80
319 Item 22031 103.00 104.75
320 Item 22036 61.80 62.85
321 Item 22041 41.20 41.90
322 Item 22042 20.60 20.95
323 Item 22051 185.40 188.55
324 Item 22055 247.20 251.40
325 Item 22060 618.00 628.50
326 Item 22065 103.00 104.75
327 Item 22075 309.00 314.25
328 Item 22900 123.60 125.70
329 Item 22905 123.60 125.70
330 Item 23010 20.60 20.95
331 Item 23025 41.20 41.90
332 Item 23035 61.80 62.85
333 Item 23045 82.40 83.80
334 Item 23055 103.00 104.75
335 Item 23065 123.60 125.70
336 Item 23075 144.20 146.65
337 Item 23085 164.80 167.60
338 Item 23091 185.40 188.55
339 Item 23101 206.00 209.50
340 Item 23111 226.60 230.45
341 Item 23112 247.20 251.40
342 Item 23113 267.80 272.35
343 Item 23114 288.40 293.30
344 Item 23115 309.00 314.25
345 Item 23116 329.60 335.20
346 Item 23117 350.20 356.15
347 Item 23118 370.80 377.10
348 Item 23119 391.40 398.05
349 Item 23121 412.00 419.00
350 Item 23170 432.60 439.95
351 Item 23180 453.20 460.90
352 Item 23190 473.80 481.85
353 Item 23200 494.40 502.80
354 Item 23210 515.00 523.75
355 Item 23220 535.60 544.70
356 Item 23230 556.20 565.65
357 Item 23240 576.80 586.60
358 Item 23250 597.40 607.55
359 Item 23260 618.00 628.50
360 Item 23270 638.60 649.45
361 Item 23280 659.20 670.40
362 Item 23290 679.80 691.35
363 Item 23300 700.40 712.30
364 Item 23310 721.00 733.25
365 Item 23320 741.60 754.20
366 Item 23330 762.20 775.15
367 Item 23340 782.80 796.10
368 Item 23350 803.40 817.05
369 Item 23360 824.00 838.00
370 Item 23370 844.60 858.95
371 Item 23380 865.20 879.90
372 Item 23390 885.80 900.85
373 Item 23400 906.40 921.80
374 Item 23410 927.00 942.75
375 Item 23420 947.60 963.70
376 Item 23430 968.20 984.65
377 Item 23440 988.80 1005.60
378 Item 23450 1,009.40 1026.55
379 Item 23460 1,030.00 1047.50
380 Item 23470 1,050.60 1068.45
381 Item 23480 1,071.20 1089.40
382 Item 23490 1,091.80 1110.35
383 Item 23500 1,112.40 1131.30
384 Item 23510 1,133.00 1152.25
385 Item 23520 1,153.60 1173.20
386 Item 23530 1,174.20 1194.15
387 Item 23540 1,194.80 1215.10
388 Item 23550 1,215.40 1236.05
389 Item 23560 1,236.00 1257.00
390 Item 23570 1,256.60 1277.95
391 Item 23580 1,277.20 1298.90
392 Item 23590 1,297.80 1319.85
393 Item 23600 1,318.40 1340.80
394 Item 23610 1,339.00 1361.75
395 Item 23620 1,359.60 1382.70
396 Item 23630 1,380.20 1403.65
397 Item 23640 1,400.80 1424.60
398 Item 23650 1,421.40 1445.55
399 Item 23660 1,442.00 1466.50
400 Item 23670 1,462.60 1487.45
401 Item 23680 1,483.20 1508.40
402 Item 23690 1,503.80 1529.35
403 Item 23700 1,524.40 1550.30
404 Item 23710 1,545.00 1571.25
405 Item 23720 1,565.60 1592.20
406 Item 23730 1,586.20 1613.15
407 Item 23740 1,606.80 1634.10
408 Item 23750 1,627.40 1655.05
409 Item 23760 1,648.00 1676.00
410 Item 23770 1,668.60 1696.95
411 Item 23780 1,689.20 1717.90
412 Item 23790 1,709.80 1738.85
413 Item 23800 1,730.40 1759.80
414 Item 23810 1,751.00 1780.75
415 Item 23820 1,771.60 1801.70
416 Item 23830 1,792.20 1822.65
417 Item 23840 1,812.80 1843.60
418 Item 23850 1,833.40 1864.55
419 Item 23860 1,854.00 1885.50
420 Item 23870 1,874.60 1906.45
421 Item 23880 1,895.20 1927.40
422 Item 23890 1,915.80 1948.35
423 Item 23900 1,936.40 1969.30
424 Item 23910 1,957.00 1990.25
425 Item 23920 1,977.60 2011.20
426 Item 23930 1,998.20 2032.15
427 Item 23940 2,018.80 2053.10
428 Item 23950 2,039.40 2074.05
429 Item 23960 2,060.00 2095.00
430 Item 23970 2,080.60 2115.95
431 Item 23980 2,101.20 2136.90
432 Item 23990 2,121.80 2157.85
433 Item 24100 2,142.40 2178.80
434 Item 24101 2,163.00 2199.75
435 Item 24102 2,183.60 2220.70
436 Item 24103 2,204.20 2241.65
437 Item 24104 2,224.80 2262.60
438 Item 24105 2,245.40 2283.55
439 Item 24106 2,266.00 2304.50
440 Item 24107 2,286.60 2325.45
441 Item 24108 2,307.20 2346.40
442 Item 24109 2,327.80 2367.35
443 Item 24110 2,348.40 2388.30
444 Item 24111 2,369.00 2409.25
445 Item 24112 2,389.60 2430.20
446 Item 24113 2,410.20 2451.15
447 Item 24114 2,430.80 2472.10
448 Item 24115 2,451.40 2493.05
449 Item 24116 2,472.00 2514.00
450 Item 24117 2,492.60 2534.95
451 Item 24118 2,513.20 2555.90
452 Item 24119 2,533.80 2576.85
453 Item 24120 2,554.40 2597.80
454 Item 24121 2,575.00 2618.75
455 Item 24122 2,595.60 2639.70
456 Item 24123 2,616.20 2660.65
457 Item 24124 2,636.80 2681.60
458 Item 24125 2,657.40 2702.55
459 Item 24126 2,678.00 2723.50
460 Item 24127 2,698.60 2744.45
461 Item 24128 2,719.20 2765.40
462 Item 24129 2,739.80 2786.35
463 Item 24130 2,760.40 2807.30
464 Item 24131 2,781.00 2828.25
465 Item 24132 2,801.60 2849.20
466 Item 24133 2,822.20 2870.15
467 Item 24134 2,842.80 2891.10
468 Item 24135 2,863.40 2912.05
469 Item 24136 2,884.00 2933.00
470 Item 25000 20.60 20.95
471 Item 25005 41.20 41.90
472 Item 25010 61.80 62.85
473 Item 25013 20.60 20.95
474 Item 25014 20.60 20.95
475 Item 25020 41.20 41.90

Health Insurance (Pathology Services Table) Regulations 2020

122  Subclause 2.14.1 of Schedule 1 (heading)

Omit “1 July 2021”, substitute “1 July 2022”.

123  Subclause 2.14.1(1) of Schedule

Repeal the subclause, substitute:

(1)  On 1 July 2022 (the indexation day), the amount of a fee for an item in Group P12 is replaced by the amount worked out using the following formula:

Note:          The indexed fees could in 2022 be viewed on the Department of Health’s MBS Online website (

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0